Immuron
IMRN
2 hedge funds and large institutions have $57K invested in Immuron in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
41% less capital invested
Capital invested by funds: $96K → $57K (-$39K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.1K |
IMRN Hedge Fund Activity: Q3 2017 in Review
2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q3 2017, worth a combined $57K — down 41% from $96K a quarter earlier.
Fund positioning in IMRN was balanced in Q3 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $3.1K.
- 2 institutional investors held Immuron (IMRN) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $57K of Immuron stock for Q3 2017, down 41% quarter-over-quarter.
- 0 funds opened new Immuron positions in Q3 2017 and 0 closed out.
- The largest Immuron seller in Q3 2017 was UBS Group, an estimated $3.1K sold.
Based on aggregated 13F filings for Q3 2017.